Some Good Funding News About Drug-Resistant Bacteria

If the proposed Congressional deal goes through, funding to study antimicrobial resistance will increase from $471 million to $774 million. Unfortunately, AHRQ (Agency for Healthcare Research and Quality), which studies hospital and medical interventions, will be cut from $364 million to $334 million (those keeping score at home will remember that Republicans hate AHRQ because they believe it is ‘death panel’ research)

This entry was posted in Funding, NIH. Bookmark the permalink.